All the news

1st participation at 10th congress of Imaging in Ophtalmology

1st participation at 10th congress of Imaging in Ophtalmology

OphtAI continues its journey with its first participation at the 10th Ophtalmic Imaging congress (https://www.vuexplorer.com/en/congres)! A big thank-you to Dr.Michel Puech and the VuExplorer Institue team for this congress. Join us at the next meeting for OphtAI :

Join us at AAO

Join us at AAO

Evolucare team will be pleased to welcome you at AAO (American Academy of Ophtalmology) in San Francisco, USA from 12 to 15 October 2019 to present its innovative solutions OphtAI, AI to detect eye pathologies. Come and join us at West Exhibit Hall, booth 7610 to ...

OphtAI is back from the summer break!

OphtAI is back from the summer break!

Following its high profile launch at the French Ophthalmology Society Convention in May, OphtAI, the new  pure player in AI for ophthalmology, is back from the summer break with a program of flagship events. Always at the cutting edge of technology, OphtAI is once ...

Now launching OphtAI, a joint venture in artificial intelligence for ophthalmology

Now launching OphtAI, a joint venture in artificial intelligence for ophthalmology

On 12 May 2019, Evolucare and its partner ADCIS, specializing in image analysis in a range of fields, including ophthalmology, chose the French Ophthalmology Society International Convention (125th edition, 11-14 May 2019, Palais des Congrès de Paris) to ratify ...

Evolucare OphtAI, finalist at the HIT Innovations Awards 2019

Evolucare OphtAI, finalist at the HIT Innovations Awards 2019

We are proud to announce that our new product, Evolucare OphtAI was a finalist in the Prevention & Diagnosis category at the 2019 HIT Innovations Awards, organized as part of Paris Healthcare Week! HIT Innovations Trophées reward the most innovative businesses ...

Need more information ?

 

OphtAI is a Joint Venture specialized in Artificial Intelligence for Eye Care. Would you like to find out more about our solutions or meet our teams?

By continuing your navigation, you allow us to use an anonymous audience measurement cookie. Privacy Policy